Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
about
Science review: role of coagulation protease cascades in sepsisAnticoagulants and Statins As Pharmacological Agents in Free Flap Surgery: Current RationaleLipid oxidation enhances the function of activated protein C.Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke.Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin.Protein S as an in vivo cofactor to activated protein C in prevention of microarterial thrombosis in rabbits.Protein C replacement in severe meningococcemia: rationale and clinical experience.Endogenous plasma activated protein C levels and the effect of enoxaparin and drotrecogin alfa (activated) on markers of coagulation activation and fibrinolysis in pulmonary embolism.Receptors of the protein C activation and activated protein C signaling pathways are colocalized in lipid rafts of endothelial cells.Safety and antithrombotic efficacy of moderate platelet count reduction by thrombopoietin inhibition in primates.Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated).Thrombin activatable fibrinolysis inhibitor (TAFI)--how does thrombin regulate fibrinolysis?Antibody SPC-54 provides acute in vivo blockage of the murine protein C system.A biologically active surface enzyme assembly that attenuates thrombus formation.Thrombin.Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XIAnticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein CImmobilization of actively thromboresistant assemblies on sterile blood-contacting surfaces.Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation.Rational Design of Protein C Activators.Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo.Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.Protein C pathway, antiphospholipid antibodies and thrombosis.The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C.Protein C and other cofactors involved in the binding of antiphospholipid antibodies: relation to the pathogenesis of thrombosis.Human activated protein C variants in a rat model of arterial thrombosis.Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients.Microparticles in deep venous thrombosis, antiphospholipid syndrome and Factor V Leiden.Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation.Upregulation of the antithrombotic protein C pathway at birth.Antithrombotic agents in the treatment of severe sepsis.Thrombin enhances the barrier function of rat microvascular endothelium in a PAR-1-dependent manner.Thrombin generation test for evaluation of antiplatelet treatment in patients with coronary artery disease after percutaneous coronary intervention.Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.Assessment of the thrombogenic effect of fibrin sealant dressing in a vascular surgery model in rabbits.In vivo veritas: Thrombosis mechanisms in animal models
P2860
Q24794146-7239E29A-6045-482D-889D-424AC41E66DEQ26776077-CA2FA360-69B5-439D-8FC3-F75DF5F6FF0AQ31509260-BF827A8D-5101-434B-9674-24157DD66E92Q33879440-D22D1362-9F03-4781-A615-495BA589EA7BQ33931868-08A1AE17-23F2-4B38-AA8B-99F24FD142CDQ34214354-B96B689E-5A16-4C9E-A80F-26905C387906Q34219618-EF9B7063-088C-48B9-8138-F30C818762A8Q35567223-C764A176-63FD-4706-9606-848AE7EB58BFQ35669786-3635DCB9-C2FD-4572-BE8E-CA33CC5B4E4DQ35728878-9075C5A0-B7B6-4A53-A2BF-56C7690531A4Q35804490-2FA2DA40-EE4E-4335-80D2-EEF795719BDAQ36259602-EEC6D980-4328-43D4-9819-8E687FA7D491Q36606627-AB554D5C-3189-4195-94E6-A17548FECB49Q36674553-A2D7088D-F826-4938-BBFC-83687F50D2EBQ36712188-88673A29-C5E7-4AE1-AB53-754F94AF9489Q36800534-739718D9-66A6-453D-B83A-541268A35DFAQ37071138-6BABE009-3128-4C71-953A-97ACC27A7302Q37368145-FCCAFC79-D920-45E5-8631-1E49ED600182Q37640471-7E7A75AE-3E46-4131-ADAC-7D3577CEF478Q37671483-BADA616C-9C8A-40D0-B34F-17D489CA1ECCQ37704695-BA3DEF85-6FB4-40E6-8586-8D66F1360438Q40251372-9B88EF44-4A20-446D-8E6C-1A6E17100F89Q40302136-56DEAC50-EF67-4079-BEEB-86E7CA100C40Q40558476-AB9A9EEC-C415-4E11-975D-EA0DF9A4E520Q41087128-29D5D81B-5D40-43E3-9369-2A6A1687C51AQ41197517-45BE9612-FBB7-4B31-80E5-701A5D029FE5Q42009597-8CA9419A-8D4C-484E-B1E6-86439E72B8FBQ42745163-76F18ECC-6C1B-44EF-AC65-EEDA6F0E91CFQ43265582-A10D7553-3A13-4975-AB6B-D81EAFA846CFQ43665945-B6169460-ABDA-4696-BD82-A7193C2AB1E5Q46341728-B75A88AC-56D8-458D-BBA5-E539382592E5Q46576624-910A4698-16AA-4B56-8EE2-9784BC7F765AQ46847448-E27D14A1-047A-4DCC-B2D7-138CA77B8B1FQ47901992-9F40C498-DB27-495E-844E-25500D74DFEFQ49960669-B455ECC2-43E2-483E-9906-BE7D4FFF0E23Q51105068-8D442E55-4281-4DC3-AD3A-F573205EA9DEQ58863655-375793CD-85A0-4009-921A-2F8CF09997B4
P2860
Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.
description
1993 nî lūn-bûn
@nan
1993 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Antithrombotic effects of thro ...... ogenous protein C in primates.
@ast
Antithrombotic effects of thro ...... ogenous protein C in primates.
@en
type
label
Antithrombotic effects of thro ...... ogenous protein C in primates.
@ast
Antithrombotic effects of thro ...... ogenous protein C in primates.
@en
prefLabel
Antithrombotic effects of thro ...... ogenous protein C in primates.
@ast
Antithrombotic effects of thro ...... ogenous protein C in primates.
@en
P2093
P2860
P356
P1476
Antithrombotic effects of thro ...... ogenous protein C in primates.
@en
P2093
P2860
P304
P356
10.1172/JCI116795
P407
P577
1993-10-01T00:00:00Z